X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Blister pack with dollars instead of pills In the midst of a pandemic, the drug industry is likely at least in the short term to see a boost to its bottom lines. (Photo: Shutterstock)

Just as other products have seen sales and profits go through the roof as people stocked up on goods in response to lockdowns, pharmaceutical company Eli Lilly has not only beat quarterly estimates but also boosted its profit forecast for 2020 as customers have stocked up on such drugs as its diabetes drug Trulicity and psoriasis drug Taltz.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

Marlene Satter

Marlene Y. Satter has worked in and written about the financial industry for decades.

More from this author

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.